Endometriosis affects 1 in 10 Canadians, yet its financial toxicity remains poorly understood. While universal healthcare covers physician and hospital services, patients face substantial out-of-pocket costs for medications, complementary therapies, …
Endometriosis is a prevalent gynecological condition often requiring invasive procedures for diagnosis. This study aimed to assess mesothelin (MSLN) as a potential non-invasive biomarker by analyzing its levels in peritoneal …
Endometriosis, a disease affecting about one out of ten women, is characterized by the growth of endometrial-like tissue outside the uterine cavity. There is significant disease heterogeneity, but the pathophysiological …
Researchers issue warning after discovering overlooked threat to reproductive health: 'More significant effects' Yahoo
Elite Women’s Health: Why Endometriosis Must Be a Priority Medical Tourism Magazine
Integrating inflammatory biomarkers and demographic variables with machine learning to predict endometriosis risk Nature
Research Challenges Menstrual Taboo, Promotes Inclusion Mirage News
Amazon has matched Best Buy's stunning AirPods offer — get AirPods 4 for their lowest-ever price Mashable
Exploring the combined antiproliferative effects of artesunate and resveratrol in Ishikawa endometrial cancer cells News-Medical
Endometriosis Treatment Market at $1.55B, 7.7% CAGR openPR.com